Estimating the optimal rate of adjuvant chemotherapy utilization for stage III colon cancer

BACKGROUND: Identifying optimal chemotherapy utilization rates can drive improvements in quality of care. We report a benchmarking approach to estimate the optimal rate of adjuvant chemotherapy (ACT) for stage III colon cancer. METHODS: The Ontario Cancer Registry and linked treated records were use...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Cancer Med
Main Authors: Karim, Safiya, Booth, Christopher M., Brennan, Kelly, Peng, Yingwei, Siemens, D. Robert, Krzyzanowska, Monika K., Mackillop, William J.
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Clinical Cancer Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745837/
https://ncbi.nlm.nih.gov/pubmed/31407518
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2456
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares